Zealand Pharma News and Activities

Zealand Pharma is a company listed under the stock ticker ZEAL (DK).

View the org chart displaying its 41 main executives

Most searched biographies at Zealand Pharma

• Adam Steensberg, President and Chief Executive Officer
• Kirsten Drejer, Vice Chairman of the Board
• Anneline Nansen, Director

Popular executive movements at Zealand Pharma

• Camilla Sylvest has joined the company as Director  (posted on May 4 2026).
• Eric Rojas has joined the company as Vice President and Head of Investor Relations  (posted on April 15 2026).

Create your alert
to follow the executive moves at Zealand Pharma.

Zealand Pharma has 2,426 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• The new name of ChemoTech is Neem’s Hill. (posted on July 14 2026).
• MindRank has just announced a $52 Million fundraising (posted on July 14 2026).
• Chemomab and Scipher Medicine have announced they will merge  (posted on July 13 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Zealand Pharma

• Zealand Pharma to participate in the Jefferies London Healthcare Conference
• Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
• Zealand Pharma Announces Financial Results for the First Nine Months of 2024
• Zealand Pharma conference call on November 7 at 2pm CET (8am ET) to present third quarter 2024 financial results
• Zealand Pharma announces that Boehringer receives U.S. FDA Breakthrough Therapy designation and initiates two Phase III trials in MASH for survodutide
• Zealand Pharma provides U.S. regulatory update on dasiglucagon in congenital hyperinsulinism
• Total number of shares and voting rights in Zealand Pharma A/S on September 30, 2024
• Zealand Pharma to participate in the 2024 Cantor Global Healthcare Conference on September 18th
• Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants
• Zealand Pharma announces positive topline results from 13-week Phase 1b multiple ascending dose clinical trial with GLP-1/GLP-2 receptor dual agonist dapiglutide
• View more press releases Close

Social media about Zealand Pharma

• Zealand Pharma on Wikipedia, Google News & Yahoo Finance
• Zealand Pharma on LinkedIn, X (Twitter) & YouTube